32.7 C
New York
Friday, June 12, 2026

Tag: ticker

James Altucher: Starlink Authorized to Deploy Thousands More Satellites.

James Altucher walks through what Starlink's expanding constellation signals about the company's future and why most investors haven't connected the dots.
James Altucher walks through what Starlink's expanding constellation signals about the company's future and why most investors haven't connected the dots.

Starlink Now Drives the Majority of SpaceX’s Revenue. James Altucher’s Presentation Explains How That Shapes the IPO.

Ahead of the expected June 12 listing, longtime tech analyst examines how a satellite service became the company's primary profit engine.
Ahead of the expected June 12 listing, longtime tech analyst examines how a satellite service became the company's primary profit engine.

Defiance Launches the First Autism-Impact ETF (Ticker: ASD), Donating Profits to Autism Causes *

Defiance Launches the First Autism-Impact ETF (Ticker: ASD), Donating Profits to Autism Causes

VEON Closes USD 1.4 Billion Bond Offering, Refinancing 2027 Notes Ahead of Schedule

Dubai and New York, June 2, 2026 – VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON” or the “Company”), today announces the successful closing of a USD 1.4 billion dual-tranche senior unsecured notes offering (the “Offering”) by its subsidiary VEON Midco B.V. (the “Issuer”). The Offering refinances substantially all of VEON’s debt maturing in 2027 ahead of schedule and reflects sustained confidence in VEON’s digital operator transformation and AI1440 strategy.

ICIS expands polymer demand insight to help customers make better decisions across global plastics markets

LONDON, June 2, 2026 /PRNewswire/ -- ICIS, a global leader in commodity intelligence, announced it has acquired the AMI Plastics Market Intelligence Dataset, strengthening its ability...

ICIS expands polymer demand insight to help customers make better decisions across global plastics markets

LONDON, June 2, 2026 /PRNewswire/ -- ICIS, a global leader in commodity intelligence, announced it has acquired the AMI Plastics Market Intelligence Dataset, strengthening its ability...

Inventiva Announces Temporary Trading Halt of its Ordinary Shares on Euronext Paris

Daix (France), New York City (New York, United States), June 2, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announces that the listing of its ordinary shares on the regulated market of Euronext Paris will be temporarily halted, at the Company's request, from the opening of the market at 9:00 a.m. CEST.

Altucher Breaks Down What Happens Next For SpaceX

With a Nasdaq listing targeted for June 12, the longtime early stage technology investor walks through the timeline investors are watching.
With a Nasdaq listing targeted for June 12, the longtime early stage technology investor walks through the timeline investors are watching.

Tribeca Strategic Acquisition Corp. Announces Closing of $140,000,000 Initial Public Offering

New York, June 01, 2026 (GLOBE NEWSWIRE) -- Tribeca Strategic Acquisition Corp. (the “Company”), announced today the closing of its initial public offering of 14,000,000 units at a price of $10.00 per unit, which resulted in gross proceeds of $140,000,000. The units are listed on the Nasdaq Global Market (“Nasdaq”) and began trading on May 29, 2026, under the ticker symbol “BIDWU.” Each unit consists of one Class A ordinary share and one right (the “Share Right”) to receive one tenth (1/10) of one Class A ordinary share upon the consummation of an initial business combination.  There are no warrants issued publicly or privately in connection with this offering. Once the securities constituting the units begin separate trading, the Class A ordinary shares and Share Rights are expected to be listed on Nasdaq under the symbols “BID” and “BIDWR,” respectively.

Nxera’s Vamorolone Granted Key Regulatory Designations Supporting Faster Access for Duchenne Muscular Dystrophy Patients in South Korea

Tokyo, Japan and Cambridge, UK, 2 June 2026 – Nxera Pharma Co., Ltd. (“Nxera” or the “Company”)  announces that the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea has granted Orphan Drug Designation (ODD) and Global Innovative Products on Fast Track (GIFT) designation to vamorolone for the treatment of Duchenne muscular dystrophy (DMD). The Company plans to submit a Marketing Authorization Application (MAA) for vamorolone in South Korea during 2026.

WAMCO DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Western Asset Management Company, LLC Mutual Fund Investors with Losses in Excess of $100K to Secure Counsel...

NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the “Western Asset US Core Bond Fund” mutual fund classes – Class I (ticker: “WATFX”), Class A (ticker: “WABAX”), Class C (ticker: “WABCX”), Class FI (ticker: “WAPIX”), Class IS (ticker: “WACSX”), and Class R (ticker: “WABRX”) – and the “Western Asset Core Plus Bond Fund” mutual fund classes – Class A (ticker: “WAPAX”), Class C (ticker: “WAPCX”), Class C1 (ticker: “LWCPX”), Class FI (ticker: “WACIX”), Class R (ticker: “WAPRX”), Class I (ticker: “WACPX”), Class IS (ticker: “WAPSX”) between January 1, 2021 and October 31, 2023, inclusive (the “Class Period”), of the important September 5, 2025 lead plaintiff deadline.

Gemini Files Registration Statement with SEC for Proposed Initial Public Offering

NEW YORK, Aug. 15, 2025 /PRNewswire/ -- Gemini Space Station, Inc. ("Gemini"), a global crypto platform, today announced that it has publicly filed a...

rYojbaba Co., Ltd. Announces Closing of $5 Million Initial Public Offering of Japanese Common Shares

FUKUOKA, Japan, Aug. 15, 2025 (GLOBE NEWSWIRE) -- rYojbaba Co., Ltd. (Nasdaq: RYOJ) (“rYojbaba” or the “Company”), a Japanese labor consulting and health services company, today announced the closing of its initial public offering of 1,250,000 Japanese common shares at a public offering price of US$4.00 per share. The total gross proceeds from the offering, before deducting underwriting discounts and other offering expenses payable by rYojbaba, was US$5 million. rYojbaba’s Japanese common shares began trading on the Nasdaq Capital Market on August 14, 2025, under the ticker symbol “RYOJ”.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsTicker